Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia

MN. Dworzak, B. Buldini, G. Gaipa, R. Ratei, O. Hrusak, D. Luria, E. Rosenthal, JP. Bourquin, M. Sartor, A. Schumich, L. Karawajew, E. Mejstrikova, O. Maglia, G. Mann, WD. Ludwig, A. Biondi, M. Schrappe, G. Basso, International-BFM-FLOW-network,

. 2018 ; 94 (1) : 82-93. [pub] 20170221

Language English Country United States

Document type Journal Article

Grant support
NV15-28525A MZ0 CEP Register

Immunophenotyping by flow cytometry (FCM) is a worldwide mainstay in leukemia diagnostics. For concordant multicentric application, however, a gap exists between available classification systems, technologic standardization, and clinical needs. The AIEOP-BFM consortium induced an extensive standardization and validation effort between its nine national reference laboratories collaborating in immunophenotyping of pediatric acute lymphoblastic leukemia (ALL). We elaborated common guidelines which take advantage of the possibilities of multi-color FCM: marker panel requirements, immunological blast gating, in-sample controls, tri-partite antigen expression rating (negative vs. weak or strong positive) with capturing of blast cell heterogeneities and subclone formation, refined ALL subclassification, and a dominant lineage assignment algorithm able to distinguish "simple" from bilineal/"complex" mixed phenotype acute leukemia (MPAL) cases, which is essential for choice of treatment. These guidelines are a first step toward necessary inter-laboratory standardization of pediatric leukemia immunophenotyping for a concordant multicentric application. © 2017 International Clinical Cytometry Society.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028806
003      
CZ-PrNML
005      
20201022094905.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cyto.b.21518 $2 doi
035    __
$a (PubMed)28187514
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dworzak, Michael N $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
245    10
$a AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia / $c MN. Dworzak, B. Buldini, G. Gaipa, R. Ratei, O. Hrusak, D. Luria, E. Rosenthal, JP. Bourquin, M. Sartor, A. Schumich, L. Karawajew, E. Mejstrikova, O. Maglia, G. Mann, WD. Ludwig, A. Biondi, M. Schrappe, G. Basso, International-BFM-FLOW-network,
520    9_
$a Immunophenotyping by flow cytometry (FCM) is a worldwide mainstay in leukemia diagnostics. For concordant multicentric application, however, a gap exists between available classification systems, technologic standardization, and clinical needs. The AIEOP-BFM consortium induced an extensive standardization and validation effort between its nine national reference laboratories collaborating in immunophenotyping of pediatric acute lymphoblastic leukemia (ALL). We elaborated common guidelines which take advantage of the possibilities of multi-color FCM: marker panel requirements, immunological blast gating, in-sample controls, tri-partite antigen expression rating (negative vs. weak or strong positive) with capturing of blast cell heterogeneities and subclone formation, refined ALL subclassification, and a dominant lineage assignment algorithm able to distinguish "simple" from bilineal/"complex" mixed phenotype acute leukemia (MPAL) cases, which is essential for choice of treatment. These guidelines are a first step toward necessary inter-laboratory standardization of pediatric leukemia immunophenotyping for a concordant multicentric application. © 2017 International Clinical Cytometry Society.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a dítě $7 D002648
650    _2
$a konsensus $7 D032921
650    _2
$a průtoková cytometrie $x normy $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $x normy $7 D016130
650    _2
$a fenotyp $7 D010641
650    _2
$a akutní lymfatická leukemie $x diagnóza $7 D054198
655    _2
$a časopisecké články $7 D016428
700    1_
$a Buldini, Barbara $u Laboratory of Pediatric Onco-Hematology, Women and Child Department, University of Padova, Padova, Italy.
700    1_
$a Gaipa, Giuseppe $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
700    1_
$a Ratei, Richard $u Clinic for Oncology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
700    1_
$a Hrusak, Ondrej $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Luria, Drorit $u Department of Pediatric Hematology and Oncology, Schneider's Children's Medical Center, Petach-Tikva, Israel.
700    1_
$a Rosenthal, Eti $u Cancer Research Center and the Hematology Laboratory, Jeffrey Modell Foundation (JMF) Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
700    1_
$a Bourquin, Jean-Pierre $u Division of Oncology and Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland.
700    1_
$a Sartor, Mary $u Flow Cytometry Unit, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, Australia.
700    1_
$a Schumich, Angela $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
700    1_
$a Karawajew, Leonid $u Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany.
700    1_
$a Mejstrikova, Ester $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Maglia, Oscar $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
700    1_
$a Mann, Georg $u Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
700    1_
$a Ludwig, Wolf-Dieter $u Clinic for Oncology and Tumor Immunology, HELIOS Klinikum Berlin-Buch, Berlin, Germany.
700    1_
$a Biondi, Andrea $u Tettamanti Research Center and Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy.
700    1_
$a Schrappe, Martin $u Department of Pediatrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
700    1_
$a Basso, Giuseppe $u Laboratory of Pediatric Onco-Hematology, Women and Child Department, University of Padova, Padova, Italy.
710    2_
$a International-BFM-FLOW-network
773    0_
$w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 94, č. 1 (2018), s. 82-93
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28187514 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20201022094902 $b ABA008
999    __
$a ok $b bmc $g 1433955 $s 1067266
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 94 $c 1 $d 82-93 $e 20170221 $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
GRA    __
$a NV15-28525A $p MZ0
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...